Drugs
Updated FDA Hepatic Function Guidance Explained
The FDA Guidance Recap Broadcast recently explained updated agency guidance on “Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosage.” Office of Clinical Pharmacology regulatory scientific reviewer Martina Sahre first discussed the importance of studying the effect of hepatic impairment in drug development. She